The iCAF subpopulation is detected in invasive pancreatic cancer, and iCAFs exhibit elevated expression of VIM, FAP, COL3A1, DES, IL6, and CXCL12 and reduced expression of ACTA2 (coding α-SMA). This evidence concerns the gene ACTA2 and familial pancreatic carcinoma.